Kay Clark

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

Anita F. Das, P. Fernandes, D. Oldach, 2013, Antimicrobial Agents and Chemotherapy.

A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.

T. Degenhardt, Anita F. Das, G. Corey, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects

T. Degenhardt, M. Gutierrez, P. Fernandes, 2011, Antimicrobial Agents and Chemotherapy.

Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects

K. Rodvold, P. Fernandes, Kay Clark, 2012, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of Solithromycin (CEM-101) Using Data from the Plasma and Epithelial Lining Fluid of Healthy Subjects

S. Bhavnani, P. Ambrose, K. Rodvold, 1986 .

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).

B. Rowe, K. Keedy, Anita F. Das, 2016, The Lancet. Infectious diseases.

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis

C. Fichtenbaum, J. Vazquez, A. Reboli, 2008, Journal of acquired immune deficiency syndromes.

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

D. Benjamin, T. Walsh, N. Seibel, 2006, Antimicrobial Agents and Chemotherapy.

Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin

K. Keedy, K. Waites, Anita F. Das, 2015 .

Population Pharmacokinetics of Fusidic Acid: Rationale for Front-Loaded Dosing Regimens Due to Autoinhibition of Clearance

S. Bhavnani, P. Ambrose, J. Bulitta, 2012, Antimicrobial Agents and Chemotherapy.

(Range) Mean Tmax (Range) Mean WBC (x10^9/mL) (Range) Mean CRP (mg/L) (Range) Mean Serum

K. Keedy, K. Waites, Anita F. Das, 2015 .

Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.

T. Degenhardt, M. Gutierrez, P. Fernandes, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.